Sanguina is a wellness and diagnostic company offering at-home anemia management tools, through app technology and an over-the-counter kit.
Sanguina has raised $2.8M in total funding. The most recent round was Series A. The last funding was announced in July 2023.
Sanguina's investors include National Science Foundation, XRC Ventures, Georgia Research Alliance, The Seed Lab, Veritus Holdings.
Sanguina is headquartered in Norcross, United States.
Sanguina is a wellness and diagnostic company offering at-home anemia management tools, through app technology and an over-the-counter kit.
Sanguina is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Sanguina — Funding & Investors." VCBacked, July 25, 2023, https://www.vcbacked.co/company/sanguina. Accessed August 1, 2026.
VCBacked. (2023). Sanguina — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/sanguina
{{cite web |title=Sanguina — Funding & Investors |url=https://www.vcbacked.co/company/sanguina |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated